Status:
UNKNOWN
Oxygen Assist Module in Preterm Infants on High Flow Nasal Cannula Support.
Lead Sponsor:
South Tees Hospitals NHS Foundation Trust
Collaborating Sponsors:
Vapotherm, Inc.
Conditions:
Preterm Birth
Eligibility:
All Genders
23-32 years
Phase:
NA
Brief Summary
Oxygen treatment is common in babies born early (preterm) and requiring intensive care. Having too much or too little oxygen can increase the risk of damage to the eyes and lungs, and contribute to de...
Detailed Description
Supplemental oxygen remains by far the most commonly used 'drug' in neonatal intensive care units. The goal of oxygen therapy is to maintain normal oxygenation while minimizing hypoxemia and hypoxemia...
Eligibility Criteria
Inclusion
- Preterm infants {born at a gestation \<33 weeks (23+0 to 32+6 weeks) }
- Receiving HFNC as respiratory support anytime during their stay in the neonatal support
Exclusion
- Preterm infants more than equal to 33 weeks.
- Preterm infants with major congenital or chromosomal anomalies
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04687618
Start Date
April 15 2021
End Date
April 30 2023
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James Cook University Hospital
Middlesbrough, United Kingdom, TS4 3BW